Matis Medical

Company Overview

Snapshot

Founded in January 2000, Matis Medical operates with 1–10 employees. The company is in a Pre-Funding stage, focusing on the commercialization of its Cone and Plate(let) Analyzer (CPA) technology, which was patented through Ramot, Tel Aviv University's Authority for Applied Research & Industrial Development.

Business overview

Matis Medical develops a point-of-care system for real-time, whole-blood platelet function testing, known as the Cone and Plate(let) Analyzer (CPA). Its initial products, the Impact and Impact-R, are designed for screening congenital primary hemostasis abnormalities and testing platelet response to various medications. The company serves the health tech and life sciences sectors, targeting clinical and point-of-care laboratories with its medical technologies and diagnostic devices.

Company Intelligence Q&A

What is Matis Medical's primary focus?

Matis Medical focuses on developing a point-of-care system for real-time, whole-blood platelet function testing, utilizing its patented Cone and Plate(let) Analyzer (CPA) technology.

When was Matis Medical founded?

Matis Medical was founded in January 2000.

What products does Matis Medical offer?

Matis Medical's first two products are the Impact and the Impact-R, which are designed for platelet function testing.

What is the status of Matis Medical's products?

The Impact system for clinical and point-of-care laboratories is currently in development and is not yet commercially available.

Who invented the core technology behind Matis Medical's products?

The CPA technology was invented by Prof. David Varon and Prof. Naphtali Savion and patented through Ramot, the Authority for Applied Research & Industrial Development of Tel Aviv University, Israel.